Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Amplifier-molecules-for-enhancement-of-diagnosis-and-therapy

 Polyoxypropylene/polyoxyethylene copolmers with improved biological activity
Although the prior art preparations of polyoxypropylene/polyoxyethylene block copolymers may have ...


 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
We claim: 1. A compound of the formula ##STR10## where (a) X.sup.1 is chlorine and X.sup.2 is ...


 Nucleic acid probes immobilized on polystyrene surfaces
We claim: 1. An article of manufacture for use in a solution phase nucleic acid sandwich ...


 Star polymers having multiple polyisobutylene arms emanating from a calixarene core, initiators therefor, and method for the synthesis thereof
What is claimed is: 1. A composition of matter comprising: a core component selected from the group ...


 High molecular weight polymer-based prodrugs
The present invention addresses the shortcomings described above. In one aspect of the invention, ...


 Non-antigenic branched polymer conjugates
OF THE INVENTION 1. POLYMER SUBSTITUENTS AND FORMULA (I) DEFINED The activated branched polymers ...


 Substantially pure histidine-linked protein polymer conjugates
In one aspect, the present invention includes substantially pure protein-polymer conjugates. The ...


 Crosslinked polymer compositions and methods for their use
The present invention discloses a crosslinked polymer composition comprising a first synthetic ...


 Conjugation of polypeptides
OF THE INVENTION It is the object of the invention to provide polypeptide conjugates with reduced ...


 High molecular weight polymer-based prodrugs
OF THE INVENTION A. THE PRODRUGS In most aspects of the invention, the prodrug compositions of the ...


 Amplifier molecules for enhancement of diagnosis and therapy

Details
Inventors: Keana, John F. W.;
Assignee: The State of Oregon Acting by and through the State Board of Higher (Eugene, OR)
Primary Examiner: Bond; Robert T.
Assistant Examiner: Ward; E. C.
Attorney, Agent or Firm: Klarquist, Sparkman, Campbell, Leigh & Whinston

Disclosed are amplifier molecules: various organic compounds having branched structures terminating with amine groups to which pharmacologically active groups can be chemically attached. A number of MRI contrast-enhancing agents were synthesized, each comprising plural active groups, such as stable nitroxides and complexes of trivalent metal cations. Such syntheses were successfully performed using a number of amplifiers having different branched structures, demonstrating the general utility of the pertinent chemistry in the synthesis of amplifiers having any of a wide variety of pharmacologically active groups. Amplifiers were also synthesized having linkers terminating with chemically reactive groups such as isothiocyanates, which render the amplifier bifunctional: attachable to polymers, biomacromolecules, or other biocompatible entity possessing multiple reactive sites such as terminal amines. Via such chemistry, the amplifiers are attachable to monoclonal antibodies for concentration of pharmacologically active groups at a desired site in the body.

DETAILED DESCRIPTION As used herein, an "amplifier" or "amplifier molecule" is a chemical compound having a multiplicity of terminal amine moieties, each serving as a locus to which one or two of any of several desired functional groups can be chemically attached, thereby allowing the synthesis of branched molecules having a multiplicity of functional groups per molecule.
As described herein, chemical groups having pharmacologic utility can be attached to the terminal amines of amplifier molecules, yielding molecules having an enhanced effect over molecules having only one such group.
An "amplification factor" refers to the number of terminal amines present in each amplifier molecule.
For example, a molecule with an amplification factor of six has six terminal amines.
Each terminal amine, in turn, can accept either one or two functional groups, depending on the particular group added thereto, in place of the hydrogen atoms.
Any of the amplified pharmacological compounds of the present invention may be introduced into the body of a human or other warm-blooded animal by any pharmacologically suitable carrier.
Generally, buffered isotonic saline solution is the carrier of choice.
Compounds intended for diagnostic use are generally administered intravenously such as presently done, for example, with gadolinium-DTPA for MRI contrast enhancement.
The following basic methods and equipment were used during the work resulting in the present invention: Melting points were obtained on a Thomas Hoover apparatus and were uncorrected.
NMR spectra were recorded on a Nicolet QE 300 spectrometer in CDCl.
sub.
3 unless otherwise stated.
Chemical shifts are expressed in d units relative to tetramethylsilane (Me.
sub.
4 Si).
IR spectra were recorded on a Nicolet DX-FT IR spectrometer in CDCl.
sub.
3 solvent unless otherwise stated.
Elemental analyses were determined by Desert Analytics, Tucson, Ariz.
All reactions were routinely run under N.
sub.
2 atmosphere.
For flash chromatography, Grade 633, 200-425 mesh 60



Related patents
  Peptide-containing polyethylene glycol derivatives and application thereof
OF THE PREFERRED EMBODIMENTS The present invention will hereinafter be explained in more detail. The peptide-containing polyethylene glycol derivatives of the present ...
  Modified HIL-6
OF THE INVENTION Described below is the chemical modification with PEG of at least one amino group of polypeptides possessing IL-6 activities. This modification results ...
  Construction of geometrical objects from polynucleotides
By means of the present invention, DNA, RNA and similar polymers may be produced by synthesizing a double stranded segment, preferably with a loop at one end, cleaving ...
  Starburst conjugates
In its broadest aspect, the present invention is directed to polymer conjugate materials comprising dense star polymers or starburst polymers associated with desired ...
  Intermediates for providing functional groups on the 5' end of oligonucleotides
We claim: 1. A partially protected alcohol of the formula: ##STR10## wherein Y.sup.1 is selected from dimethoxytrityl, monomethoxytrityl, trityl or pixyl, Y.sup.2 is ...
  Antiviral polynucleotide conjugates
OF THE INVENTION The present invention provides polynucleotide conjugates characterized by the properties of ligand binding and enhanced stability. In the present ...
  Azlactone activated polyalkylene oxides conjugated to biologically active nucleophiles
OF THE PREFERRED EMBODIMENT The azlactone activated polyalkylene oxides of the present invention are preferably prepared from polyalkylene oxides that are soluble in ...
  Biologically compatible linear block copolymers of polyalkylene oxide and peptide units
INCLUSIVE OF PREFERRED EMBODIMENTS We have discovered that linear block copolymers comprising blocks of poly(alkylene oxide) (PAGs) and peptides attached via --CH.sub.2 ...
  Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
The present invention provides for compounds having the formula: ##STR1## wherein R.sub.1 is selected from the group consisting of an N-benzotriazole group, an N-2-...
  Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
OF THE INVENTION The following examples are given to illustrate the invention, but should not be considered in limitation of the invention: Example 1--Synthesis of CH....

0.994

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved